: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Osteoporosis

Free Subscription

Articles published in Osteoporos Int
Retrieve available abstracts of 634 articles:
HTML format

Single Articles

August 2026

INOSE H, Takahashi S, Teraguchi M, Kato T, et al
Bracing versus balloon kyphoplasty for acute osteoporotic vertebral fractures with poor prognostic radiological factors: a propensity score-matched comparison.
Osteoporos Int. 2026 Aug 15. doi: 10.1007/s00198-026-08195.
PubMed Abstract available

GHAREHKHANI M, Tronstad I, Nilsen TIL, Vikjord SAA, et al
Parity, age at first birth, breastfeeding, and risk of major osteoporotic fractures in middle-aged women. The HUNT study.
Osteoporos Int. 2026 Aug 14. doi: 10.1007/s00198-026-08155.
PubMed Abstract available

HUANG YC, Kao SW, Chen YC, Cheng MT, et al
AI-derived opportunistic screening using chest radiographs identifies age- and sex-associated bone mineral density patterns and supports earlier osteoporosis evaluation.
Osteoporos Int. 2026 Aug 14. doi: 10.1007/s00198-026-08192.
PubMed Abstract available

JUENJA M, Ramteke H, Khan R
Comment on "Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis".
Osteoporos Int. 2026 Aug 13. doi: 10.1007/s00198-026-08124.
PubMed

BIGDON SF, Scherer J, Camino-Willhuber G, Spiegl U, et al
Validation of the AO Spine Osteoporotic Fracture Classification-effect of geographical region on reliability and reproducibility.
Osteoporos Int. 2026 Aug 13. doi: 10.1007/s00198-026-08112.
PubMed Abstract available

PASCHALIS EP, Gamsjaeger S, Hassler N, Bare SP, et al
Bone organic matrix quality indices associate with fragility fracture occurrence independently of bone mineral density values.
Osteoporos Int. 2026 Aug 13. doi: 10.1007/s00198-026-08182.
PubMed Abstract available

LIU C, Yang D, Xu T, Fu H, et al
Prevalence and risk factors of bone fragility in duchenne muscular dystrophy: A systematic review and meta-analysis.
Osteoporos Int. 2026 Aug 11. doi: 10.1007/s00198-026-08174.
PubMed Abstract available

FU SC, Wang CY, Fu SH
Author response to original letter, manuscript no. OSIN-D-26-01474, "Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk".
Osteoporos Int. 2026 Aug 10. doi: 10.1007/s00198-026-08173.
PubMed

ROBERTS AGK, Wong PKK, Williamson J, Center J, et al
A systemwide approach to secondary fracture prevention-the New South Wales Osteoporosis Refracture Prevention Initiative was associated with reduced refractures and was economically sustainable.
Osteoporos Int. 2026 Aug 7. doi: 10.1007/s00198-026-08140.
PubMed Abstract available

AHMADI M, Sargolzaeimoghaddam M, Mohseni V, Sargolzaeimoghaddam M, et al
The incidence and predictors of falling in older adults: the results of follow-up in Iranian multicenter osteoporosis study (IMOS).
Osteoporos Int. 2026 Aug 6. doi: 10.1007/s00198-026-08183.
PubMed Abstract available

PELZL CE, Narayan AK, Prout TM, Binkley NC, et al
Trends and disparities in DXA testing for osteoporosis among Medicare beneficiaries, 2005-2023.
Osteoporos Int. 2026 Aug 6. doi: 10.1007/s00198-026-08083.
PubMed Abstract available

HUMMEL LS, Blaschke M, Lamersdorf A, Lehmann G, et al
Low alkaline phosphatase in adults: implications for the diagnosis of hypophosphatasia during evaluation for osteoporosis.
Osteoporos Int. 2026 Aug 5. doi: 10.1007/s00198-026-08161.
PubMed Abstract available

July 2026

LI E, Mirzayeh Fashami F, Kane S, McTavish R, et al
The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price.
Osteoporos Int. 2026 Jul 31. doi: 10.1007/s00198-026-08153.
PubMed Abstract available

YI M, Zhu S, Wang X, Yu Z, et al
Intramuscular fat infiltration is associated with higher vertebral void space burden and lower volumetric bone mineral density in older adults.
Osteoporos Int. 2026 Jul 30. doi: 10.1007/s00198-026-08162.
PubMed Abstract available

WU PH, Lin YT, Chen JC, Lin SY, et al
Author response to OSIN-D-26-01484: "Clarifying statistical methods in a TriNetX analysis of statins and osteoporosis in CKD patients".
Osteoporos Int. 2026 Jul 29. doi: 10.1007/s00198-026-08167.
PubMed

WANG J
Clarifying statistical methods in a TriNetX analysis of statins and osteoporosis in CKD patients.
Osteoporos Int. 2026 Jul 29. doi: 10.1007/s00198-026-08166.
PubMed

ZAINAB S, Zaheer L, Sheikh AR, Khalid MS, et al
Comparative efficacy of biosimilar denosumab and reference denosumab in treatment of postmenopausal osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2026 Jul 29. doi: 10.1007/s00198-026-08159.
PubMed Abstract available

SAND R, Adams AL, Gilfillan AD, Ryan DS, et al
Manual chart review reveals bisphosphonate exposure misclassification in atypical femur fracture patients: auditing medical records in two international cohorts.
Osteoporos Int. 2026 Jul 28. doi: 10.1007/s00198-026-08144.
PubMed Abstract available

QU J, Wang G
Letter to the Editor: Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study.
Osteoporos Int. 2026 Jul 27. doi: 10.1007/s00198-026-08121.
PubMed

HAN X, Yang M
Letter to the editor regarding "Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk".
Osteoporos Int. 2026 Jul 24. doi: 10.1007/s00198-026-08171.
PubMed

JUDE M, Breasail MO, Bird S, Mesinovic J, et al
Osteoporosis and post-fracture management in the primary care setting: a systematic review.
Osteoporos Int. 2026 Jul 22. doi: 10.1007/s00198-026-08157.
PubMed Abstract available

UEMURA K, Otake Y, Soufi M, Kono S, et al
Side-to-side differences in hip bone mineral density and associated morphological factors.
Osteoporos Int. 2026 Jul 22. doi: 10.1007/s00198-026-08141.
PubMed Abstract available

ZHANG Y, Duan Z, Liu J, Tian C, et al
A comprehensive evaluation of seven osteoporosis screening tools.
Osteoporos Int. 2026 Jul 20. doi: 10.1007/s00198-026-08118.
PubMed Abstract available

RASHID A, Hauge SC, Nielsen BR, Zerahn B, et al
Reply to: high prevalence of sarcopenia, osteoporosis and osteosarcopenia in patients with chronic kidney disease compared with healthy controls.
Osteoporos Int. 2026 Jul 18. doi: 10.1007/s00198-026-08131.
PubMed

PAPAGEORGIOU M, Gugler Y, Ferrari S, Rizzoli R, et al
Dietary and supplemental calcium intake and bone changes during antiresorptive osteoporosis treatment in older women: a longitudinal observational study.
Osteoporos Int. 2026 Jul 17. doi: 10.1007/s00198-026-08154.
PubMed Abstract available

PAL R, Banerjee M, Yadav U, Patra S, et al
Influence of bisphosphonate pretreatment on bone mineral density gains and fracture outcomes with teriparatide: A systematic review and meta-analysis.
Osteoporos Int. 2026 Jul 15. doi: 10.1007/s00198-026-08136.
PubMed Abstract available

KORKMAZ HA, Kahveci A
Clinical insights into the association between chronic liver disease and osteoporosis.
Osteoporos Int. 2026 Jul 13. doi: 10.1007/s00198-026-08135.
PubMed Abstract available

DEHNE N, von Brackel FN, Gunzl C, Barvencik F, et al
Romosozumab in severe postmenopausal osteoporosis-real-world data from 192 women.
Osteoporos Int. 2026 Jul 8. doi: 10.1007/s00198-026-08127.
PubMed Abstract available

BAE SJ, Lee SH, Lee MJ, Kim EH, et al
Association between myosteatosis and bone mineral density in postmenopausal women.
Osteoporos Int. 2026 Jul 2. doi: 10.1007/s00198-026-07872.
PubMed Abstract available

June 2026

FERRARI S, Hars M, Biver E, Uebelhart B, et al
Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates.
Osteoporos Int. 2026 Jun 29. doi: 10.1007/s00198-026-08115.
PubMed Abstract available

CHANDRAN M, Wong CMJ, Helgason B, Leong YE, et al
Revisiting the Osteoporosis Self-Assessment Tool (OST): evidence from a multi-cohort study in Asia supporting age-dependent thresholds.
Osteoporos Int. 2026 Jun 26. doi: 10.1007/s00198-026-08123.
PubMed Abstract available

AWAIS AM, Awais AR, Saad M, Mahsud NJ, et al
Parkinson's disease severity and treatment classification in interpreting bisphosphonate-associated fracture risk.
Osteoporos Int. 2026 Jun 24. doi: 10.1007/s00198-026-08055.
PubMed

CHANDRAN M, Anastasilakis AD, Blank RD, Binkley N, et al
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporo
Osteoporos Int. 2026 Jun 18. doi: 10.1007/s00198-026-08086.
PubMed Abstract available

TSENG TH, Huang TT, Huang JE, Tzeng SC, et al
AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study.
Osteoporos Int. 2026 Jun 18. doi: 10.1007/s00198-026-08100.
PubMed Abstract available

DIZ-LOPES M, Rovetta CF, Pollastri F, Mastropaolo F, et al
Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study.
Osteoporos Int. 2026 Jun 18. doi: 10.1007/s00198-026-08113.
PubMed Abstract available

CHANDRAN M, Mitchell P, Ebeling PR, Mithal A, et al
Regional data, global lessons: what the Asia-Pacific osteoporosis audit teaches the world.
Osteoporos Int. 2026 Jun 12. doi: 10.1007/s00198-026-08097.
PubMed Abstract available

JING LQ, Chen C, Fang YD, Wang JN, et al
Association between vestibular dysfunction and osteoporosis in adults: a systematic review and meta-analysis.
Osteoporos Int. 2026 Jun 8. doi: 10.1007/s00198-026-08094.
PubMed Abstract available

YANG J, Cao D, Du C
Letter to the editor regarding "Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study".
Osteoporos Int. 2026 Jun 5. doi: 10.1007/s00198-026-08092.
PubMed

LIU X, Hu K, Zhu T
The gut-bone-inflammation axis: intestinal barrier disruption as a central driver of osteoporosis.
Osteoporos Int. 2026 Jun 3. doi: 10.1007/s00198-026-07855.
PubMed Abstract available

FU SC, Lu YC, Sie NH, Hung CC, et al
Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk.
Osteoporos Int. 2026 Jun 2. doi: 10.1007/s00198-026-08081.
PubMed Abstract available

ALDEGHERI F, Rossini M, Viapiana O
Response to: Letter to the editor regarding: Real?world rebound pattern of serum collagen type I C?telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment?induced bone loss.
Osteoporos Int. 2026 Jun 2. doi: 10.1007/s00198-026-08074.
PubMed

May 2026

QU X, Yi M, Tang X, Chen B, et al
Reconsidering fracture risk reduction in Parkinson's disease: limitations of claims-based inference.
Osteoporos Int. 2026 May 30. doi: 10.1007/s00198-026-08091.
PubMed

HUANG CC, Chu YC
Biomechanical heterogeneity of Tai Chi styles may influence bone mineral density responses.
Osteoporos Int. 2026 May 30. doi: 10.1007/s00198-026-08087.
PubMed

XU N, Liu P, Liu C, Zhu Z, et al
Efficacy of denosumab versus zoledronate on preventing secondary osteoporotic vertebral compression fracture: a prospective study with 2-year follow-up.
Osteoporos Int. 2026 May 20. doi: 10.1007/s00198-026-08049.
PubMed Abstract available

KIM B, Lee KN, Han K, Kim MK, et al
Diabetes progression and its association with fracture risk in type 2 diabetes.
Osteoporos Int. 2026 May 20. doi: 10.1007/s00198-026-08079.
PubMed Abstract available

GOEL H, Spector E, Yardley G, Mosiman S, et al
Use of DXA-based software to identify astronauts at risk for persisting spaceflight-induced bone loss.
Osteoporos Int. 2026 May 19. doi: 10.1007/s00198-026-07875.
PubMed Abstract available

CRABTREE N, King B, Ayya M, Shaw N, et al
Bone densitometry findings and prevalence of osteoporosis at initial scanning in girls with anorexia nervosa.
Osteoporos Int. 2026 May 18. doi: 10.1007/s00198-026-07996.
PubMed Abstract available

HUANG CF, Fang WH, Chen KH, Lin SY, et al
Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region.
Osteoporos Int. 2026 May 16. doi: 10.1007/s00198-026-08067.
PubMed Abstract available

LORENTZON M, Wahlstrand V, Alven J, Haggstrom I, et al
Vertebral fractures identified on lateral DXA images by deep learning predict incident fractures in older women.
Osteoporos Int. 2026 May 12. doi: 10.1007/s00198-026-08072.
PubMed Abstract available

LYNCH LK, Kamanda-Kosseh M, Agarwal S, Shane E, et al
Postpartum timing of teriparatide initiation and BMD response in pregnancy- and lactation-associated osteoporosis: an observational study.
Osteoporos Int. 2026 May 11. doi: 10.1007/s00198-026-08061.
PubMed Abstract available

BURDEN AM, la Torre AM, Immoos M, Burkard T, et al
Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study.
Osteoporos Int. 2026 May 11. doi: 10.1007/s00198-026-08002.
PubMed Abstract available

WANG PC, Su H, Wu LC, Kuo YJ, et al
Fragility fractures of the pelvis and long-term outcomes among older adults with osteoporosis: a real-world cohort study.
Osteoporos Int. 2026 May 9. doi: 10.1007/s00198-026-08060.
PubMed Abstract available

FERNANDEZ-GONZALEZ M, Mora-Traverso M, Molina-Garcia P, Prieto-Moreno R, et al
Effectiveness and safety of physical exercise and health education for the management of osteoporotic vertebral fractures: a systematic review and meta-analysis.
Osteoporos Int. 2026 May 8. doi: 10.1007/s00198-026-07994.
PubMed Abstract available

LIU C, Chai F, Sang B
Letter to the editor regarding "Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss".
Osteoporos Int. 2026 May 8. doi: 10.1007/s00198-026-08075.
PubMed

ZHANG B, Gu J, Lu R, Dong Y, et al
Correction to: Association of frailty trajectories with osteoporosis and hip fracture in an older female population.
Osteoporos Int. 2026 May 5. doi: 10.1007/s00198-026-08050.
PubMed

BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
Soluble klotho levels and hip fracture risk in the elderly.
Osteoporos Int. 2026 May 1. doi: 10.1007/s00198-026-08053.
PubMed Abstract available

April 2026

CHOUDHURI B
Comment on - Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease: clinical caveats beyond a one-year claims analysis.
Osteoporos Int. 2026 Apr 30. doi: 10.1007/s00198-026-08057.
PubMed

SCALA A, Delbarba A, Ceolin C, Camozzi V, et al
Impact of reference gender on bone mineral density and fracture risk assessment in transgender adults.
Osteoporos Int. 2026 Apr 30. doi: 10.1007/s00198-026-07995.
PubMed Abstract available

TEH HW, Lee YL, Musa NH, Thilakavathy K, et al
Preserved bone mineral density in autosomal dominant SP7-related osteogenesis imperfecta: a case report of the p.Glu340Ala variant.
Osteoporos Int. 2026 Apr 30. doi: 10.1007/s00198-026-08029.
PubMed Abstract available

PRABAHAR K, Alharthi NM, AlKenani R
Incidence and risk factors of hypocalcemia following denosumab therapy in a Saudi osteoporosis cohort.
Osteoporos Int. 2026 Apr 29. doi: 10.1007/s00198-026-07953.
PubMed

JIN Y, Lao Z, Liu J
Letter to the editor regarding: 'Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohort'.
Osteoporos Int. 2026 Apr 29. doi: 10.1007/s00198-026-07954.
PubMed

YANG N, Zheng K
Letter to the editor concerning "Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease".
Osteoporos Int. 2026 Apr 29. doi: 10.1007/s00198-026-08054.
PubMed

SHAO Y, Yang X, Shi Q, Xu Z, et al
Osteoporosis in rheumatoid arthritis: a new perspective on risk factors and clinical prediction models.
Osteoporos Int. 2026 Apr 28. doi: 10.1007/s00198-026-08059.
PubMed Abstract available

LIAO KF, Lai SW
Methodological considerations on the association between osteoporosis and cataracts.
Osteoporos Int. 2026 Apr 28. doi: 10.1007/s00198-026-08058.
PubMed

KIM S, Han KD, Jung J, Cho H, et al
Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study.
Osteoporos Int. 2026 Apr 28. doi: 10.1007/s00198-026-08028.
PubMed Abstract available

ZHANG T, Wang K, Song Y
Comment on: Outcome evaluation of osteoporosis patient education: an observational study comparing an intervention group and matched control group.
Osteoporos Int. 2026 Apr 23. doi: 10.1007/s00198-026-07966.
PubMed

PICHAT CSH, Ballegaard ELF, Bressendorff IO, Jorgensen HS, et al
Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease.
Osteoporos Int. 2026 Apr 22. doi: 10.1007/s00198-026-08035.
PubMed Abstract available

SMITH M, Roast J, Collins GS, Holt TA, et al
Development and external validation of prediction models for major osteoporotic fracture and hip fracture in people with intellectual disability.
Osteoporos Int. 2026 Apr 20. doi: 10.1007/s00198-026-07848.
PubMed Abstract available

RASHID A, Hauge SC, Nielsen BR, Zerahn B, et al
High prevalence of sarcopenia, osteoporosis and osteosarcopenia in patients with chronic kidney disease compared with healthy controls.
Osteoporos Int. 2026 Apr 20. doi: 10.1007/s00198-026-08008.
PubMed Abstract available

JAISWAL R, Zoulakis M, Axelsson KF, Litsne H, et al
The systemic inflammation response index is independently associated with incident fracture risk in older women.
Osteoporos Int. 2026 Apr 20. doi: 10.1007/s00198-026-08022.
PubMed Abstract available

HATANO M, Okada A, Sasabuchi Y, Kimura Y, et al
Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study.
Osteoporos Int. 2026 Apr 17. doi: 10.1007/s00198-026-08026.
PubMed Abstract available

DESAI A, Khataniar H, Habib H, Hashash JG, et al
Increased osteoporosis burden and comparative antiresorptive effectiveness in inflammatory bowel disease: a real-world cohort study.
Osteoporos Int. 2026 Apr 17. doi: 10.1007/s00198-026-08020.
PubMed Abstract available

CAPASSO A, Arpaia C, Panicucci C, Gulli C, et al
Vertebral fractures and muscle function in glucocorticoid-treated individuals with Duchenne muscular dystrophy: a cohort study.
Osteoporos Int. 2026 Apr 17. doi: 10.1007/s00198-026-07990.
PubMed Abstract available

WU PH, Lin YT, Chen JC, Lin SY, et al
High-potency statins are associated with reduced osteoporosis but increased fracture risk in CKD patients: a multi-center retrospective study.
Osteoporos Int. 2026 Apr 15. doi: 10.1007/s00198-026-08021.
PubMed Abstract available

GHIELMETTI A, Grassi G, Carrara S, Palermo A, et al
Romosozumab super-responders in clinical practice: insights from a large Italian multicenter cohort of women with severe postmenopausal osteoporosis.
Osteoporos Int. 2026 Apr 14. doi: 10.1007/s00198-026-07999.
PubMed Abstract available

NGUYEN HT, Nguyen TV, Ho-Pham LT
Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study.
Osteoporos Int. 2026 Apr 13. doi: 10.1007/s00198-026-07989.
PubMed

NGUYEN HT, Thai NHT, Nguyen TV, Ho-Pham LT, et al
Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study.
Osteoporos Int. 2026 Apr 13. doi: 10.1007/s00198-026-07973.
PubMed

MATTA M, Harris BHL, Koizia LJ
Rethinking body composition in vertebral fracture risk assessment.
Osteoporos Int. 2026 Apr 13. doi: 10.1007/s00198-026-07972.
PubMed

VON BRACKEL FN, Bartosik M, Munzinger R, Barvencik F, et al
Calcium isotope ratio (delta(44/42)Ca) reflects kidney function and calcium excretion but not bone mineral density or bone turnover: a cross-sectional study.
Osteoporos Int. 2026 Apr 11. doi: 10.1007/s00198-026-07935.
PubMed Abstract available

TSAI SHL, Chen YH, Yang CY, Lee CY, et al
Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study.
Osteoporos Int. 2026 Apr 10. doi: 10.1007/s00198-026-07968.
PubMed Abstract available

LUBBAD O, Hagos A, Lubbad L, El-Tahlawy Y, et al
Diagnostic performance of lumbar computed tomography Hounsfield unit thresholds for osteoporosis and osteopenia: a systematic review and meta-analysis.
Osteoporos Int. 2026 Apr 10. doi: 10.1007/s00198-026-07863.
PubMed Abstract available

BIN Z, Jinguang G, Ru L, Yongli D, et al
Association of frailty trajectories with osteoporosis and hip fracture in an older female population.
Osteoporos Int. 2026 Apr 9. doi: 10.1007/s00198-026-07980.
PubMed Abstract available

HAABER RS, Langdahl B, Nelissen R, Jensen SS, et al
Mental disorders and osteoporosis treatment in patients with hip fracture-a Danish population-based cohort study.
Osteoporos Int. 2026 Apr 9. doi: 10.1007/s00198-026-07975.
PubMed Abstract available

DIZ LOPES M, Fassio A, Bianco B, Andreola S, et al
Comparative longitudinal assessment of bone mineral density measured with radiofrequency echographic multi-spectrometry (REMS) and dual X-ray absorptiometry (DXA) in a cohort of peritoneal dialysis patients.
Osteoporos Int. 2026 Apr 9. doi: 10.1007/s00198-026-07959.
PubMed Abstract available

NIIMI R, Kobayakawa T, Etani Y, Noguchi T, et al
Baseline serum PINP is associated with early lumbar spine bone mineral density gains during twice-weekly teriparatide treatment: the OASIS cohort study.
Osteoporos Int. 2026 Apr 6. doi: 10.1007/s00198-026-07985.
PubMed Abstract available

GUNGOR M, Bayat A, Esme M
Comment on "Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial" (Os
Osteoporos Int. 2026 Apr 1. doi: 10.1007/s00198-026-07970.
PubMed

WEAVER AA, Shapses SA, Stapleton J, Greene KA, et al
Authors' reply to 2nd comment on: effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized
Osteoporos Int. 2026 Apr 1. doi: 10.1007/s00198-026-07971.
PubMed

NARLA R, McCoy K, Mengeling MA, Davila H, et al
Who receives DXA in VHA direct care vs. community care? Insights into bone health care for veterans.
Osteoporos Int. 2026;37:991-997.
PubMed Abstract available

FIOROTTO OLR, Machado LG, Caparbo VF, Lopes JB, et al
Clinical utility of one-third radius BMD in a population-based prospective cohort of older adults: Insights from the Sao Paulo Aging & Health (SPAH) study.
Osteoporos Int. 2026;37:893-903.
PubMed Abstract available

GERALDI MV, Brattemark E, Lorentzon M
Longitudinal associations of dietary intake, physical activity, and short-chain fatty acids with bone development in early postmenopausal women.
Osteoporos Int. 2026;37:879-892.
PubMed Abstract available

March 2026

NASOMYONT N, Tian C, Hornung L, Khoury J, et al
The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density.
Osteoporos Int. 2026 Mar 30. doi: 10.1007/s00198-026-07963.
PubMed Abstract available

CHEN J, Huang D, Lou D
Effects of health education on treatment adherence, dietary supplement use, and disease health knowledge among people with osteoporosis: a meta-analysis.
Osteoporos Int. 2026 Mar 27. doi: 10.1007/s00198-026-07942.
PubMed Abstract available

ING SW, McDermott M, Yeh E, Lane JM, et al
Clinical impact of acute symptomatic vertebral fractures in the United States: A patient survey and chart review.
Osteoporos Int. 2026 Mar 25. doi: 10.1007/s00198-026-07951.
PubMed Abstract available

FERRARI S, Seefried L, Pall D, Viapiana O, et al
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.
Osteoporos Int. 2026 Mar 24. doi: 10.1007/s00198-026-07964.
PubMed Abstract available

VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
Correction: A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
Osteoporos Int. 2026 Mar 24. doi: 10.1007/s00198-026-07957.
PubMed

HOU M, Jin S, Luo J, Yang L, et al
Comparative efficacy of different traditional Chinese exercises on bone mineral density in older adults: a systematic review and network meta-analysis.
Osteoporos Int. 2026 Mar 22. doi: 10.1007/s00198-026-07945.
PubMed Abstract available

RICHARDSON-THORNTON I, Brennan SC, Liu L, Streeter C, et al
A new age of osteoanabolic therapy? A real-world, two-centre study comparing effects of romosozumab, teriparatide, and antiresorptive therapies for osteoporosis.
Osteoporos Int. 2026 Mar 20. doi: 10.1007/s00198-025-07808.
PubMed Abstract available

KANG S, Choi NJ, Han K, Park Y, et al
Impact of splenectomy on fracture risk via the bone-immune axis: A nationwide Korean cohort study.
Osteoporos Int. 2026 Mar 20. doi: 10.1007/s00198-026-07930.
PubMed Abstract available

TAN W, He T, Li J
Research progress of drug-induced osteoporosis.
Osteoporos Int. 2026 Mar 16. doi: 10.1007/s00198-026-07941.
PubMed Abstract available

LU M, Zhou H, Li X, Zhang F, et al
Comment on: Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial : To
Osteoporos Int. 2026 Mar 13. doi: 10.1007/s00198-026-07946.
PubMed

STAPLETON J, Greene KA, Leng X, Lenchik L, et al
Authors' reply to comment on: Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized con
Osteoporos Int. 2026 Mar 13. doi: 10.1007/s00198-026-07922.
PubMed

JAYASWAL RP, Kholiya K
Letter comments on: a programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study.
Osteoporos Int. 2026 Mar 12. doi: 10.1007/s00198-026-07944.
PubMed

REN J, Liu M, Wang B, Bai C, et al
Secondary fracture risk after hip fracture in older patients: an updated sex-specific systematic review and meta analysis with GRADE and PAF assessment.
Osteoporos Int. 2026 Mar 12. doi: 10.1007/s00198-026-07949.
PubMed Abstract available

WOISETSCHLAGER M, Baldimtsi E, Lindblom M, Davidson T, et al
Clinical implementation of AI for vertebral fracture detection in CT aligned with fracture liaison services: high prevalence of undiagnosed vertebral fractures.
Osteoporos Int. 2026 Mar 10. doi: 10.1007/s00198-026-07907.
PubMed Abstract available

NICOL G, Sammut L
Bone mineral density in paediatric to young adult tennis players: a narrative review.
Osteoporos Int. 2026 Mar 9. doi: 10.1007/s00198-026-07905.
PubMed Abstract available

ALDEGHERI F, Fassio A, Appoloni M, Rotta D, et al
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.
Osteoporos Int. 2026 Mar 6. doi: 10.1007/s00198-026-07936.
PubMed Abstract available

LU M, Zhou H, Li S, He L, et al
Comment on post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis.
Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-026-07926.
PubMed

SCHINI M, Johansson H, Harvey NC, Lorentzon M, et al
A meta-analysis of smoking and fracture risk to update the FRAX(R) tool.
Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-026-07853.
PubMed Abstract available

LO JC, Chandra M, Lee C
Response to "Comment on: The association of bone density and hip fracture risk among Asian women".
Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-025-07829.
PubMed

LO JC, Chandra M, Lee C
Response to "T-score, stature and fracture risk interpretation in Asian women".
Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-025-07830.
PubMed

RASMUSSEN NH, Kvist AV, Bech AA, Lykkeboe S, et al
Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort.
Osteoporos Int. 2026;37:703-716.
PubMed Abstract available

February 2026

GUO X, Wang J, Wang Y, Sun Q, et al
The impact of Tai Chi on osteoporosis and osteopenia in middle-aged and elderly adults: a systematic review and meta-analysis of randomized controlled trial.
Osteoporos Int. 2026 Feb 24. doi: 10.1007/s00198-026-07910.
PubMed Abstract available

JANG MU, Kim MS, Hwang J, Kim HS, et al
Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease.
Osteoporos Int. 2026 Feb 23. doi: 10.1007/s00198-026-07906.
PubMed Abstract available

FITZGERALD C, Burley C, Wright K, McLeod K, et al
Exercise improves quality of life, mental health and pain in people living with osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2026 Feb 20. doi: 10.1007/s00198-026-07876.
PubMed Abstract available

KENDLER DL, Habert J, Khan AA, Kherani RB, et al
Clarifying clinically treatment-naive status for osteoporosis patients.
Osteoporos Int. 2026 Feb 17. doi: 10.1007/s00198-026-07864.
PubMed Abstract available

WANDELL P, Li X, Ranch Lundin H, Carlsson AC, et al
The recurrence of osteoporotic fractures among first- and second-generation immigrants in Sweden.
Osteoporos Int. 2026 Feb 17. doi: 10.1007/s00198-026-07901.
PubMed Abstract available

NGUYEN HT, Nguyen TV, Ho-Pham LT
Letter of Rebuttal: Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study.
Osteoporos Int. 2026 Feb 17. doi: 10.1007/s00198-026-07897.
PubMed

PINTO D, Bruyere O, Sharma M, Blomme S, et al
"Build better bones": development, launch, and future directions of a multilingual, user-centered website for osteoporosis management.
Osteoporos Int. 2026 Feb 16. doi: 10.1007/s00198-025-07836.
PubMed Abstract available

WANG PC, Chen KE, Lin HA, Lin SF, et al
Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study.
Osteoporos Int. 2026 Feb 16. doi: 10.1007/s00198-026-07887.
PubMed Abstract available

QUINN MJ, Williams B, Crotti TN, Bowen JM, et al
Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis.
Osteoporos Int. 2026 Feb 16. doi: 10.1007/s00198-025-07786.
PubMed Abstract available

LAI SW, Liao KF
Muscle mass and vertebral fracture risk.
Osteoporos Int. 2026 Feb 16. doi: 10.1007/s00198-026-07893.
PubMed

MORADI D, Namavar A, Masoudi N
Comment on "Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: a 5-year follow-up cohort study" (Osteoporosis International, 2025).
Osteoporos Int. 2026 Feb 11. doi: 10.1007/s00198-026-07847.
PubMed

LAI SW, Liao KF
Baseline nonalcoholic fatty liver disease and future osteoporosis risk.
Osteoporos Int. 2026 Feb 10. doi: 10.1007/s00198-026-07874.
PubMed

BRAMPTON JJ, Harris BHL, Fertleman MB, Koizia LJ, et al
High fracture risk, limited evidence: rethinking osteoporosis treatment in chronic kidney disease.
Osteoporos Int. 2026 Feb 5. doi: 10.1007/s00198-026-07890.
PubMed

SAVARE L, Porcu G, Tratsevich A, Ronco R, et al
State sequence analysis for a deeper understanding of treatment adherence patterns in fragility fracture patients.
Osteoporos Int. 2026 Feb 2. doi: 10.1007/s00198-025-07834.
PubMed Abstract available

BEKELE BM, Moritz I, Ryang YM
Osteosarcopenia and vertebral fracture burden: toward integrated musculoskeletal risk assessment.
Osteoporos Int. 2026 Feb 1. doi: 10.1007/s00198-026-07852.
PubMed

YE C, Hans D, Schousboe JT, Binkley N, et al
Association between trabecular bone score and cardiovascular outcomes: a population-level historical cohort study.
Osteoporos Int. 2026;37:425-433.
PubMed Abstract available

LOPES MD, Orsolini G, Galvagni I, Rotta D, et al
Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE).
Osteoporos Int. 2026;37:447-458.
PubMed Abstract available

GIRI S, Roy A, Kumar A, Ghosh S, et al
Cadmium toxicity-related metabolic bone disease: a clinical conundrum of five cases.
Osteoporos Int. 2026;37:525-531.
PubMed Abstract available

JAIN RK
Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES).
Osteoporos Int. 2026;37:481-490.
PubMed Abstract available

January 2026

PRABAHAR K, Alharthi NM, AlKenani R
Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohort.
Osteoporos Int. 2026 Jan 30. doi: 10.1007/s00198-026-07862.
PubMed Abstract available

KIM H, Yao X, Li O, Cheng M, et al
Bisphosphonate treatment for secondary osteoporosis in children, youth, and young adults: a systematic review and meta-analysis.
Osteoporos Int. 2026 Jan 27. doi: 10.1007/s00198-025-07837.
PubMed Abstract available

AMORIM T, David NL, Moturi S, Turnquist LR, et al
Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial.
Osteoporos Int. 2026 Jan 27. doi: 10.1007/s00198-026-07846.
PubMed Abstract available

LIU Y, Ma X, Dai T, Zhang J, et al
Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis.
Osteoporos Int. 2026 Jan 23. doi: 10.1007/s00198-025-07838.
PubMed Abstract available

MENENDEZ JQ, Garcia Tellado A, Pardo Lleidas J, Hernandez Hernandez JL, et al
Hypercalcemia after denosumab discontinuation in patients with osteoporosis: a systematic review and case report.
Osteoporos Int. 2026 Jan 22. doi: 10.1007/s00198-026-07854.
PubMed Abstract available

CHANDRAN M, Reginster JY, Kim MY, Hiligsmann M, et al
Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA).
Osteoporos Int. 2026 Jan 21. doi: 10.1007/s00198-026-07858.
PubMed Abstract available

WEAVER AA, Greene KA, Leng X, Lenchik L, et al
Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial.
Osteoporos Int. 2026 Jan 19. doi: 10.1007/s00198-026-07845.
PubMed Abstract available

GENG S, Chen R, Liu A
Comment on: The association of bone density and hip fracture risk among Asian women.
Osteoporos Int. 2026 Jan 14. doi: 10.1007/s00198-025-07827.
PubMed

CHAO WC, Chen YH, Shih JC, Cheng B, et al
Conservative treatments for non-surgically managed osteoporotic vertebral compression fractures: a network meta-analysis of long-term pain and quality of life.
Osteoporos Int. 2026 Jan 13. doi: 10.1007/s00198-025-07823.
PubMed Abstract available

EVERTS-GRABER J, Schmid G, Hauselmann H, Huber C, et al
Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis.
Osteoporos Int. 2026 Jan 12. doi: 10.1007/s00198-025-07832.
PubMed Abstract available

HUANG CC
T-score, stature, and fracture risk interpretation in Asian women.
Osteoporos Int. 2026 Jan 12. doi: 10.1007/s00198-025-07828.
PubMed

NGUYEN HT, Nguyen BT, Nguyen QT, Tran AV, et al
Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study.
Osteoporos Int. 2026 Jan 8. doi: 10.1007/s00198-025-07831.
PubMed Abstract available

CHANG Y, Chi KY, Chen CM, Lin HM, et al
Association between SGLT2 inhibitor use and the risk of vertebral augmentation after initial osteoporotic vertebral fracture in patients with type 2 diabetes.
Osteoporos Int. 2026 Jan 8. doi: 10.1007/s00198-025-07839.
PubMed Abstract available

YAMAURA T, Maruo K, Kusukawa T, Toi M, et al
Controlling Nutritional Status (CONUT) score as a key predictor of disability following conservative treatment of osteoporotic vertebral fractures.
Osteoporos Int. 2026 Jan 5. doi: 10.1007/s00198-025-07826.
PubMed Abstract available

HIDAYAT K, Wei H, Wang LL, Rizzoli R, et al
Associations between dietary index for gut microbiota and bone health outcomes.
Osteoporos Int. 2026;37:213-222.
PubMed Abstract available

HEO J, Lee SC, Kim JH, Nam CH, et al
Prevalence of osteosarcopenia in patients with end-stage knee OA who underwent total knee arthroplasty.
Osteoporos Int. 2026;37:103-108.
PubMed Abstract available

December 2025

YAN J, Jin C
Beyond postmenopausal osteoporosis: reply to comments by Omer Faruk Oz.
Osteoporos Int. 2025 Dec 23. doi: 10.1007/s00198-025-07822.
PubMed

LAI SW
Trends of incidence and 1-year mortality of vertebral fractures in Korea.
Osteoporos Int. 2025 Dec 23. doi: 10.1007/s00198-025-07815.
PubMed

CHANG L, Chukwu N, Olenginski T, Srinivasan H, et al
A programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study.
Osteoporos Int. 2025 Dec 22. doi: 10.1007/s00198-025-07811.
PubMed Abstract available

AL-DAGHRI N, Alenad A, Alokail M, Bahat G, et al
Re: Bobelyak M, Vaculik J, Stepan JJ. Bone mineral density assessment using Radiofrequency Echographic Mult Spectrometry (REMS) in patients before and after total hip replacement, Osteoporos Int 2025;https://doi.org/10.1007/s00198-025-07685-w and Re:
Osteoporos Int. 2025 Dec 21. doi: 10.1007/s00198-025-07817.
PubMed

VITETTA L
Intestinal dysbiosis can progress ineffective bone mineral density (BMD) improvement with vitamin D in post-partum women.
Osteoporos Int. 2025 Dec 18. doi: 10.1007/s00198-025-07719.
PubMed

SUND R, Rikkonen T, Kroger H, Sirola J, et al
Burden of accumulating fragility fractures on health service usage and costs among post-menopausal women.
Osteoporos Int. 2025 Dec 16. doi: 10.1007/s00198-025-07821.
PubMed Abstract available

OZ OF
Postmenopausal osteoporosis and the global burden of fractures: a gynecologist's perspective.
Osteoporos Int. 2025 Dec 14. doi: 10.1007/s00198-025-07816.
PubMed

COHEN A, Kamanda-Kosseh M, Rawal R, Agarwal S, et al
Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis.
Osteoporos Int. 2025 Dec 14. doi: 10.1007/s00198-025-07755.
PubMed Abstract available

ZHONG J, Cao D, Liu A
Comment on: Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) - emulation of a randomized target trial.
Osteoporos Int. 2025 Dec 14. doi: 10.1007/s00198-025-07740.
PubMed

BOBELYAK M, Vaculik J, Stepan JJ, Pocock N, et al
An invited rebuttal letter. Author response to: OSIN-D-25-02044: Critical considerations on the article by Bobelyak et al. (2025) "Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after t
Osteoporos Int. 2025 Dec 14. doi: 10.1007/s00198-025-07812.
PubMed

LESLIE WD, Schousboe JT, Binkley N, Hans D, et al
Comparative effects of lumbar spine bone area from DXA on trabecular bone score and bone mineral density: the Manitoba BMD Registry.
Osteoporos Int. 2025 Dec 11. doi: 10.1007/s00198-025-07806.
PubMed Abstract available

BOBELYAK M, Vaculik J, Stepan JJ, Pocock N, et al
Author response to: OSIN-D-25-01882: Concerns regarding "Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement".
Osteoporos Int. 2025 Dec 11. doi: 10.1007/s00198-025-07789.
PubMed

FLEET JL, Carter B, Cadarette SM, Shariff SZ, et al
Fracture incidence and osteoporosis treatment in Parkinson's disease: a population-based cohort study.
Osteoporos Int. 2025 Dec 10. doi: 10.1007/s00198-025-07802.
PubMed Abstract available

ARCIDIACONO GP, Torres MO, Zanchetta F, Testoni S, et al
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis.
Osteoporos Int. 2025 Dec 10. doi: 10.1007/s00198-025-07799.
PubMed Abstract available

ARGENTIERI A, Conversano F, Casciaro S
Critical considerations on the article by Bobelyak et al. (2025) "Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement"; https://doi.org/10.1007/s00198-025-07685-w
Osteoporos Int. 2025 Dec 10. doi: 10.1007/s00198-025-07809.
PubMed

ILOMAKI J, Wood SJ, Tan GSQ, Kim SJ, et al
The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study.
Osteoporos Int. 2025 Dec 7. doi: 10.1007/s00198-025-07676.
PubMed Abstract available

BISCHOFF E, Bischoff F, Vladeva S, Kirilov N, et al
Concerns regarding "Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement".
Osteoporos Int. 2025 Dec 4. doi: 10.1007/s00198-025-07769.
PubMed

PARK D, Koh HS, Kim SB, Park JY, et al
Moderate-intensity exercise reduces osteoporotic fracture risk in older women: a dose-response analysis from a nationwide Korean cohort.
Osteoporos Int. 2025 Dec 1. doi: 10.1007/s00198-025-07766.
PubMed Abstract available

LI X, Zhao Y, Cheng L, Yan C, et al
Postoperative osteoporosis therapy and risk of re-fracture in elderly patients with hip fractures: a multicenter retrospective cohort study.
Osteoporos Int. 2025 Dec 1. doi: 10.1007/s00198-025-07757.
PubMed Abstract available

RUBAEK M, Holmberg T, Andersen S, Langdahl B, et al
Outcome evaluation of osteoporosis patient education: an observational study comparing an intervention group and matched control group.
Osteoporos Int. 2025 Dec 1. doi: 10.1007/s00198-025-07785.
PubMed Abstract available

THOMSEN LK, van Dijk Christiansen P, Andreasen CM, Andersen TL, et al
The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review.
Osteoporos Int. 2025;36:2411-2435.
PubMed Abstract available

November 2025

ABUDAYEH A, Fishchenko I
"Comment on 'Case Report on Possible Causes of Severe Osteoporosis: Diffuse Panbronchiolitis'" (Osteoporosis International, 2025).
Osteoporos Int. 2025 Nov 21. doi: 10.1007/s00198-025-07768.
PubMed

SPAGNUOLO MC, Shogry FF, Park S, Bakewell N, et al
A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture risk.
Osteoporos Int. 2025 Nov 21. doi: 10.1007/s00198-025-07745.
PubMed Abstract available

LUNN EM, Lacount S, Greene LW, Asadipooya K, et al
Management of skeletal-related events and fracture prevention in systemic mastocytosis.
Osteoporos Int. 2025 Nov 20. doi: 10.1007/s00198-025-07726.
PubMed Abstract available

LANGDAHL BL, Lorentzon M, Borgen TT, Bajtner E, et al
Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES).
Osteoporos Int. 2025 Nov 19. doi: 10.1007/s00198-025-07756.
PubMed Abstract available

NAYAK S, Greenspan SL
Correction: A systematic review and meta-analysis of sequential treatment strategies for osteoporosis.
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07751.
PubMed

LESLIE WD, Schousboe JT, Binkley N, Hans D, et al
Complementary effects of trabecular bone score and hip axis length on fracture risk: the Manitoba BMD Registry.
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07754.
PubMed Abstract available

ROLLS C, Bastiani O, Antuna M, Fair S, et al
What is the association between physical activity and fracture risk in middle-aged adults (aged 30-60): a systematic review and synthesis without meta-analysis (SWIM).
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07728.
PubMed Abstract available

JALAL AM, Media SK
Community-driven Osteoporosis Awareness Day-a successful initiative marathon day in Erbil.
Osteoporos Int. 2025 Nov 17. doi: 10.1007/s00198-025-07764.
PubMed

KHIZAR M, Alokozay E, Alokozay N
Critical appraisal of interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling.
Osteoporos Int. 2025 Nov 15. doi: 10.1007/s00198-025-07761.
PubMed Abstract available

YU P, Tang Z, Chang W, Jia L, et al
Degenerative scoliosis may trigger higher incidence of adjacent vertebral fractures following percutaneous vertebroplasty: a clinical evidence-based biomechanical research.
Osteoporos Int. 2025 Nov 12. doi: 10.1007/s00198-025-07760.
PubMed Abstract available

QI L, Gu Q, Chen B, Yang D, et al
Unmeasured confounding and ascertainment bias in the study of diabetes diagnosis age and fracture risk.
Osteoporos Int. 2025 Nov 12. doi: 10.1007/s00198-025-07767.
PubMed

ORHADJE E, Berg K, Whitehead K, Hauser B, et al
Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis: response to letter by Li and Zhang.
Osteoporos Int. 2025 Nov 5. doi: 10.1007/s00198-025-07737.
PubMed

FU T, Zhang R, Yue L, Yi X, et al
Risk factors for osteoporosis in rheumatoid arthritis patients: a meta-analysis.
Osteoporos Int. 2025 Nov 4. doi: 10.1007/s00198-025-07700.
PubMed Abstract available

LEWERIN C, Kristjansdottir HL, Entrop J, Smedby KE, et al
Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis-a national registry study of 36,864 Swedish lymphoma patients.
Osteoporos Int. 2025 Nov 4. doi: 10.1007/s00198-025-07733.
PubMed Abstract available

SONG Y, Qin Q, Zhang L, Liu X, et al
Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis.
Osteoporos Int. 2025 Nov 3. doi: 10.1007/s00198-025-07747.
PubMed Abstract available

XIAO YJ, Sun H, Huang Y, Wei XM, et al
Epileptic seizures associated with denosumab.
Osteoporos Int. 2025;36:2343-2346.
PubMed Abstract available

DASH AS, Hind K, Hans D, Nieves J, et al
Impact of standard versus cyclic teriparatide and denosumab treatment on trabecular bone score: a post-hoc analysis of a randomized clinical trial.
Osteoporos Int. 2025;36:2331-2336.
PubMed Abstract available

October 2025

ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
PubMed Abstract available

BUGBIRD AR, Burt LA, Whittier DE, Boyd SK, et al
Localized bone deterioration predicts declining failure load and increased fracture risk.
Osteoporos Int. 2025 Oct 29. doi: 10.1007/s00198-025-07750.
PubMed Abstract available

RAHMANI A, Weichelt U, Jahn D, Otto E, et al
Beyond the initial impact: a systematic review of post-traumatic bone loss and its mechanisms.
Osteoporos Int. 2025 Oct 28. doi: 10.1007/s00198-025-07716.
PubMed Abstract available

KIM J, Kwak S, Lee H, Chang J, et al
Explainable opportunistic osteoporosis screening from chest X-rays: a retrospective comparison of foundation models.
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07727.
PubMed Abstract available

FALK SSI
Author response to letter to the editor to ankle fractures: A pragmatic opportunity for osteoporosis case finding (OSIN-D-25-01889).
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07748.
PubMed

TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
Author's response to letter to editor "Comment on: Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD)-emulation of a ran
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07739.
PubMed

SENDHIL SR, Cadarette SM, Aggarwal S, Oganisian A, et al
Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07668.
PubMed Abstract available

HOSSEINPOUR M
Clarifying the interpretation of metapgs and cumulative incidence in fracture risk prediction.
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07741.
PubMed

HUANG CC
Ankle fractures: a pragmatic opportunity for osteoporosis case finding.
Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07743.
PubMed

LO JC, Chandra M, Yang W, Darbinian JA, et al
The association of bone density and hip fracture risk among Asian women.
Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07663.
PubMed Abstract available

YILDIZ AE
Letter to the editor: clinical presentation, risk factors and management of pregnancy?associated osteoporosis: a systematic review and meta?analysis.
Osteoporos Int. 2025 Oct 21. doi: 10.1007/s00198-025-07723.
PubMed

PHUNG K, Rauch D, Jackowski S, Scharke M, et al
Automated bone age calculation is an independent predictor of vertebral fracture burden in Duchenne muscular dystrophy.
Osteoporos Int. 2025 Oct 21. doi: 10.1007/s00198-025-07681.
PubMed Abstract available

XU Z, Li Y, Song H, Sit RWS, et al
The association of loneliness with bone mineral density, osteoporosis, osteopenia, fall, and sarcopenia among older adults: results from Mr. and Ms. Os (Hong Kong) study.
Osteoporos Int. 2025 Oct 18. doi: 10.1007/s00198-025-07720.
PubMed Abstract available

NAYAK S, Greenspan SL
A systematic review and meta-analysis of sequential treatment strategies for osteoporosis.
Osteoporos Int. 2025 Oct 17. doi: 10.1007/s00198-025-07717.
PubMed Abstract available

TAKEGAMI Y, Imaizumi T, Sato K, Osawa Y, et al
Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis.
Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07721.
PubMed Abstract available

KWAK MK, Lee S, Lee JY, Park JW, et al
Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study.
Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07639.
PubMed Abstract available

SEEFRIED L, Ferrari S, Pall D, Viapiana O, et al
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07711.
PubMed Abstract available

KAO SW, Huang YC, Chen YC, Cheng MT, et al
Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan.
Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07666.
PubMed Abstract available

ADAMI G, Bartezaghi M, Montanari F, Piccinelli A, et al
ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study.
Osteoporos Int. 2025 Oct 13. doi: 10.1007/s00198-025-07722.
PubMed Abstract available

SIMPSON PM, Dobson AJ, Baneshi MR, Mishra GD, et al
Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women's Health.
Osteoporos Int. 2025 Oct 12. doi: 10.1007/s00198-025-07710.
PubMed Abstract available

MACHADO M
Insufficient evidence to recommend creatine supplementation as a therapeutic option for osteoporosis.
Osteoporos Int. 2025 Oct 9. doi: 10.1007/s00198-025-07713.
PubMed

BEEKMAN MJ, Terra L, Stuursma A, Heemskerk-Gerritsen BAM, et al
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density.
Osteoporos Int. 2025 Oct 4. doi: 10.1007/s00198-025-07679.
PubMed Abstract available

September 2025

ALVI A, Parashar K, Siddiqui S, Arshad M, et al
Therapeutic potential of fish collagen hydrolysates in osteoporosis prevention: a narrative review based on cellular, molecular, and clinical evidence.
Osteoporos Int. 2025 Sep 30. doi: 10.1007/s00198-025-07698.
PubMed Abstract available

CHUN MY, Kim J
Letters to the Editor: rebuttal to OSIN-D-25-01417R1 "Letter to the editor concerning "Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study"".
Osteoporos Int. 2025 Sep 30. doi: 10.1007/s00198-025-07693.
PubMed

JHA V, Bhadada SK, Pal R, Kharbanda C, et al
Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval.
Osteoporos Int. 2025 Sep 29. doi: 10.1007/s00198-025-07703.
PubMed Abstract available

BJORNEREM A, Khoshkhabari J, Hansen AK, Borgen TT, et al
Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures.
Osteoporos Int. 2025 Sep 24. doi: 10.1007/s00198-025-07697.
PubMed Abstract available

HAN X, Xia M
Letter to the editor concerning "Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study".
Osteoporos Int. 2025 Sep 22. doi: 10.1007/s00198-025-07678.
PubMed

FALK SSI, Mittlmeier T
Should we consider ankle fractures as osteoporotic fractures?
Osteoporos Int. 2025 Sep 19. doi: 10.1007/s00198-025-07690.
PubMed Abstract available

ORHADJE E, Berg K, Whitehead K, Hauser B, et al
Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis.
Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07618.
PubMed Abstract available

MONTOYA-GARCIA MJ, Carbonell-Abella C, Garcia MG, Hernandez-Cruz B, et al
Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry.
Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07565.
PubMed Abstract available

BOBELYAK M, Vaculik J, Stepan JJ
Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement.
Osteoporos Int. 2025 Sep 10. doi: 10.1007/s00198-025-07685.
PubMed Abstract available

LO SW, Yen HK, Huang CC, Lu YC, et al
Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07670.
PubMed Abstract available

ZHANG X, Xu D, Zhang R, Wang H, et al
Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07636.
PubMed Abstract available

LIU Y, Arora T, Zhang J, Sen B, et al
Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07677.
PubMed Abstract available

CLARK P, Calo M, Bostico ST, de Pedro AO, et al
Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07684.
PubMed Abstract available

CRUZ-PRIEGO GA, Araiza-Nava B, Mendez-Sanchez L, Vargas-Chanes D, et al
Predictive capacity of fracture risk assessment tools: overview of systematic reviews.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07642.
PubMed Abstract available

KONSTANTELOS N, Kim S, Cheung AM, Burden AM, et al
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose.
Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07672.
PubMed Abstract available

TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) - emulation of a randomized target trial.
Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07687.
PubMed Abstract available

XIAO YJ, Zhou YY, Liu YQ
Zoledronic acid-induced acute psychiatric disorder.
Osteoporos Int. 2025;36:1767-1769.
PubMed Abstract available

KABRA A, Katzman WB, Lane NE, Giangregorio LM, et al
OsteoStrong and bone health: a scoping review.
Osteoporos Int. 2025;36:1521-1534.
PubMed Abstract available

LEE JH, Heo SJ, Kim KM, Lee JE, et al
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab.
Osteoporos Int. 2025;36:1661-1669.
PubMed Abstract available

PRASAD TN, Flora SS, Bhadada SK, Yadav U, et al
Anti-resorptive and anabolic therapies improve Falls Risk Assessment Score (FRAS) in postmenopausal women with type 2 diabetes mellitus.
Osteoporos Int. 2025;36:1633-1639.
PubMed Abstract available

LIN J, Tjokrosaputro PP, Ang BH, Chew CK, et al
Prolonged hypercalcemia induced by teriparatide: a case report and literature review.
Osteoporos Int. 2025;36:1763-1766.
PubMed Abstract available

BILLINGS E, Dash AS, Raphael J, Heilbronner AK, et al
Skeletal risk factors for postoperative complications in older men undergoing spinal fusion surgery.
Osteoporos Int. 2025;36:1547-1555.
PubMed Abstract available

August 2025

GUTIERREZ-HERMOSILLO H, de Leon-Gonzalez ED
Advantages of measuring hand grip strength in osteoporosis patients.
Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07680.
PubMed

DE FORD C, Guridi M, Chen Y, Murphy AP, et al
Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.
Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07651.
PubMed Abstract available

HIREDESAI AN, Holle AM, Payne CS, Beckett NC, et al
Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures.
Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07665.
PubMed Abstract available

ZENG ZJ, PengPeng, Huang CL, Yao FM, et al
More severe microdamage and micromechanical alterations: altered subchondral bone remodeling in varus knee osteoarthritis with osteoporosis.
Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07652.
PubMed Abstract available

NGUYEN HG, Nguyen DT, Tran TS, Ling SH, et al
Artificial intelligence system for predicting areal bone mineral density from plain X-rays.
Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07634.
PubMed Abstract available

MCCLOSKEY EV, Johansson H, Liu E, Akesson KE, et al
Family history of fracture and fracture risk: a meta-analysis to update the FRAX(R) risk assessment tool.
Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607.
PubMed Abstract available

JIN H, Jin H, Suk KS, Lee BH, et al
Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07661.
PubMed Abstract available

KO Y, Song BG, Shin H, Park Y, et al
Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07649.
PubMed

HARVEY NC, Al-Daghri N, Beaudart C, Brandi ML, et al
Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07628.
PubMed Abstract available

LI CC, Ou LC, Chang YF, Chang CS, et al
Performance and interventional cutoffs of osteoporosis self-assessment tools in the community: implications for screening and early referral.
Osteoporos Int. 2025 Aug 20. doi: 10.1007/s00198-025-07656.
PubMed Abstract available

DU X, Nouraie SM, Pu J, Karoleski C, et al
Lung-related risk factors associate with low bone mineral density in individuals with former tobacco exposure not meeting osteoporosis screening criteria.
Osteoporos Int. 2025 Aug 19. doi: 10.1007/s00198-025-07648.
PubMed Abstract available

SCHOTT EM, Charbonneau MR, Kiel DP, Bukata S, et al
A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.
Osteoporos Int. 2025 Aug 15. doi: 10.1007/s00198-025-07650.
PubMed Abstract available

SIAMPANOPOULOU V, Ziogas DC, Lyrarakis G, Anastasopoulou A, et al
Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysis.
Osteoporos Int. 2025 Aug 10. doi: 10.1007/s00198-025-07647.
PubMed Abstract available

CHUNG H, Kim TY, Kim J, Ha YC, et al
Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07537.
PubMed Abstract available

BORSATI A, Adamoli G, Giannarelli D, Belluomini L, et al
Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07645.
PubMed Abstract available

GU Y, Wang Y, Li M, Wang R, et al
Current applications of deep learning in vertebral fracture diagnosis.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07604.
PubMed Abstract available

CASSINAT J, Wright V
A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women.
Osteoporos Int. 2025 Aug 1. doi: 10.1007/s00198-025-07621.
PubMed Abstract available

PELEPENKO LE, de Oliveira MC, Masaro DA, Lustosa GMMM, et al
Effects of microplastics on the bones: a comprehensive review.
Osteoporos Int. 2025;36:1327-1345.
PubMed Abstract available

CHEN J, Cao L, Xu C, Lu F, et al
Modified criteria for identifying elevated bone mass.
Osteoporos Int. 2025;36:1433-1445.
PubMed Abstract available

July 2025

CHUAN F, Mei M, Liao K, Ye X, et al
DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients.
Osteoporos Int. 2025 Jul 30. doi: 10.1007/s00198-025-07644.
PubMed Abstract available

WANG X, Ji C, Li S, Wang K, et al
Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study.
Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07600.
PubMed Abstract available

NIAZI S, Mazloomi M, Ostovar A, Fahimfar N, et al
Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies.
Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07587.
PubMed Abstract available

CHUN MY, Jeon J, Chung SJ, Kim J, et al
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study.
Osteoporos Int. 2025 Jul 24. doi: 10.1007/s00198-025-07611.
PubMed Abstract available

LYU FF, Zhang M, Deng YF, Liu Q, et al
Incidence and predictors of residual back pain after percutaneous vertebral augmentation in osteoporotic vertebral compression fracture: a systematic review and meta analysis.
Osteoporos Int. 2025 Jul 23. doi: 10.1007/s00198-025-07609.
PubMed Abstract available

LIU L, Li D
Letter to the editor concerning "The impact of a fracture liaison service with in?hospital anti?osteoporosis treatment on subsequent hip fracture and mortality rates-a single?center retrospective study".
Osteoporos Int. 2025 Jul 17. doi: 10.1007/s00198-025-07433.
PubMed

GU HY, Liu N, Lin FX, Yin J, et al
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07592.
PubMed Abstract available

KNIGHT T, Eley S
Postmenopausal osteoporosis continuing education needed for healthcare professionals? A quality improvement project.
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07571.
PubMed Abstract available

LUO Z, Feng A, Tyurin A, Cui Q, et al
Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses.
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07620.
PubMed Abstract available

LLOPIS-CARDONA F, Rodriguez-Bernal CL, Hurtado I, Espallargues M, et al
Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
Osteoporos Int. 2025 Jul 12. doi: 10.1007/s00198-025-07564.
PubMed Abstract available

O'HARE B, Santaguida P, Azizudin AM, Papaioannou A, et al
The role of physical performance measures in the physiotherapy assessment and management of older adults with osteoporotic vertebral fractures: a narrative review.
Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07606.
PubMed Abstract available

ZOULAKIS M, Johansson H, Harvey NC, Axelsson KF, et al
Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study.
Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07588.
PubMed Abstract available

KO Y, Song BG, Shin H, Park Y, et al
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07602.
PubMed Abstract available

XIA L, Chi H, Cao Q
Letter to the editor about "the impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study".
Osteoporos Int. 2025 Jul 7. doi: 10.1007/s00198-025-07432.
PubMed

HARISH S, Moon RJ, Harvey NC, Inskip HM, et al
Maternal smoking before and during pregnancy and offspring bone mineral density in early childhood: findings from the Southampton Women's Survey.
Osteoporos Int. 2025 Jul 2. doi: 10.1007/s00198-025-07581.
PubMed Abstract available

MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.
Osteoporos Int. 2025;36:1231-1237.
PubMed Abstract available

FERRARI S, Akesson KE, Al-Daghri N, Biver E, et al
Bone microstructure and TBS in diabetes: what have we learned? A narrative review.
Osteoporos Int. 2025;36:1115-1128.
PubMed Abstract available

BENNETT MJ, Center JR, Carter S, Moles R, et al
Implementing pharmacist-led home medicines reviews within fracture liaison services for better post-fracture care: a qualitative study of patient and practitioner experience.
Osteoporos Int. 2025 Jul 1. doi: 10.1007/s00198-025-07589.
PubMed Abstract available

June 2025

PARK J, Kim JW, Nam JH, Kim Y, et al
Comparative analysis of osteoporotic versus pathologic fracture in metastatic colorectal cancer patients.
Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07575.
PubMed Abstract available

DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
PubMed Abstract available

ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
PubMed Abstract available

MCLAUGHLIN EC, Giangregorio LM, Adachi JD, Laing AC, et al
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.
Osteoporos Int. 2025 Jun 25. doi: 10.1007/s00198-025-07435.
PubMed Abstract available

KAMIYA K, Kojima A, Tachiki T, Imai N, et al
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07577.
PubMed Abstract available

WANG H, Zhao Y, Liu Q, Jiang Z, et al
Global burden of low bone mineral density related fractures in pre- and post-menopausal women from 1990 to 2021, with projections to 2050.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07586.
PubMed Abstract available

MOON RJ, D'Angelo S, Curtis EM, Ward KA, et al
Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07568.
PubMed Abstract available

DING Q, Zhou B, Leung J, Kwok T, et al
Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age-period-cohort analysis.
Osteoporos Int. 2025 Jun 17. doi: 10.1007/s00198-025-07570.
PubMed Abstract available

SHOGRY FF, Hayes KN, Kim S, Burden AM, et al
The rise and fall of raloxifene use for osteoporosis, 1999-2022.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544.
PubMed Abstract available

MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al
Risk factors for refracture or new vertebral compression fractures after percutaneous vertebroplasty: a systematic review and meta-analysis.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523.
PubMed Abstract available

SON HJ, Park SJ, Park JS, Han K, et al
Impact of smoking, diabetes, and exercise on dementia risk in women with osteoporosis: a nationwide cohort study.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07524.
PubMed Abstract available

TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
Authors' response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-024-07293.
PubMed

CHEN J, Zhou Q, Yu W, Cao D, et al
Renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07534.
PubMed

ZHANG Y, Ma M, Huang X, Liu J, et al
Machine learning is changing osteoporosis detection: an integrative review.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07541.
PubMed Abstract available

BUGBIRD AR, Matheson BE, Walle M, Neeteson NJ, et al
Quantifying localized bone loss in clinical computed tomography using void spaces.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07558.
PubMed Abstract available

CIROVIC A, Milovanovic P
Can adjustment for iron, zinc, and calcium levels clarify the relationship between blood cadmium and bone mineral density?
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07434.
PubMed

HUANG CF, Ho CJ, Lin SY, Hwang JS, et al
Asia-Pacific consensus for the management of osteoporosis in men.
Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559.
PubMed Abstract available

SHARAFI MH, Nazari A, Cheraghi M, Souri F, et al
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches.
Osteoporos Int. 2025 Jun 2. doi: 10.1007/s00198-025-07553.
PubMed Abstract available

BISCHOFF-FERRARI HA, Dawson-Hughes B, Orav JE, Ceglia L, et al
Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial.
Osteoporos Int. 2025;36:1007-1018.
PubMed Abstract available

May 2025

RIPPL M, Grupp P, Martini S, Muller K, et al
Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk.
Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540.
PubMed Abstract available

CHENG R, Zhang L
Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532.
PubMed Abstract available

MASHARAWI Y, Lerner A, Weisman A
Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526.
PubMed Abstract available

BERNATZ JT, Sandhu KP, Krueger D, Borchardt G, et al
Trabecular bone score predicts distal femur screw pull-out strength better than DXA bone mineral density, CT Hounsfield units, and cortical density.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07530.
PubMed Abstract available

LI H, Wang H
Association between weekend warrior physical activity pattern and bone mineral density among adults: national health and nutrition examination survey.
Osteoporos Int. 2025 May 26. doi: 10.1007/s00198-025-07535.
PubMed Abstract available

GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
Author response to: among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520.
PubMed

MONEGAL A, Carrasco JL, Peris P, Frade-Sosa B, et al
Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation.
Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07525.
PubMed Abstract available

UM YJ, Cho IY, Koo HY, Park YM, et al
Intellectual disabilities and risk of fractures: A population-based cohort study.
Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519.
PubMed Abstract available

PRAVEEN AD, Jha D, Baker A, Fleps I, et al
Comparison of the time-dependent discriminatory accuracy of femoral strength and bone mineral density for predicting future hip and major osteoporotic fractures: a 16-year follow-up of the AGES-Reykjavik cohort.
Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503.
PubMed Abstract available

ORAVEC D, Yadav RN, Cushman T, Flynn MJ, et al
Osteoporosis screening in the mammography setting via digital wrist tomosynthesis.
Osteoporos Int. 2025 May 9. doi: 10.1007/s00198-025-07516.
PubMed Abstract available

LIU E, Liu RY, Moraros J, McCloskey EV, et al
Association between walking and hip fracture in women aged 65 and older: 20-year follow-up from the study of osteoporotic fractures.
Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508.
PubMed Abstract available

WU Q, Jung J
Precision fracture risk assessment: leveraging genomic and clinical data for personalized care.
Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517.
PubMed

OUYANG W, Guo G, Zhao C
Comment on: The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430.
PubMed

April 2025

HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.
Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486.
PubMed Abstract available

ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al
Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.
Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489.
PubMed Abstract available

ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al
Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice?
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488.
PubMed Abstract available

PIGNOLO RJ, Connell JJ, Briggs W, Kelly CJ, et al
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight: validation of an AI-based tool in a US population.
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07487.
PubMed Abstract available

GORGEY AS, Venigalla S, Deitrich JN, Ballance WB, et al
Electrical stimulation paradigms on muscle quality and bone mineral density after spinal cord injury.
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07482.
PubMed Abstract available

IFTIKHAR QUA
Bridging the gap: validating AI for real-world osteoporosis screening.
Osteoporos Int. 2025 Apr 15. doi: 10.1007/s00198-025-07496.
PubMed

ORHADJE E, Makaram N, Berg K, Hauser B, et al
Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479.
PubMed Abstract available

LO HZ, Leow K, Hii R, Nerlekar N, et al
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07468.
PubMed Abstract available

LI J, Fu X, Shi H, Jing J, et al
Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies.
Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07470.
PubMed Abstract available

BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al
Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study.
Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473.
PubMed Abstract available

HAYES KN, Zullo AR, Berry SD, Oganisian A, et al
Osteoporosis medication use over time in the United States and Canada.
Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07484.
PubMed Abstract available

LIU L, Wang Y, Tan B, Huang P, et al
Association of beta-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471.
PubMed Abstract available

GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al
Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness-the osteolaus study.
Osteoporos Int. 2025;36:715-724.
PubMed Abstract available

KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).
Osteoporos Int. 2025;36:673-684.
PubMed Abstract available

VARENNA M, Zucchi F, Di Taranto R, Orsini F, et al
Osteoclast in CRPS: an alleged guilty fully acquitted.
Osteoporos Int. 2025;36:737-740.
PubMed Abstract available

PATINO-SALAZAR JD, Ovejero D, Gabernet M, Martinez-Gil N, et al
Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women.
Osteoporos Int. 2025;36:637-644.
PubMed Abstract available

WOLF JVE, Schoene D, Kohl M, Kemmler W, et al
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults - A systematic literature review and meta-analysis of randomized controlled trials.
Osteoporos Int. 2025;36:609-625.
PubMed Abstract available

March 2025

BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Internatio
Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422.
PubMed Abstract available

PAN Y, Wan Y, Wang Y, Yu T, et al
Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures.
Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338.
PubMed Abstract available

MARKARIAN AM, Taaffe DR, Bettariga F, Luo H, et al
Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis.
Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-025-07458.
PubMed Abstract available

BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452.
PubMed

SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al
Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453.
PubMed Abstract available

GERDHEM P, Wihlborg A, Bergstrom IB
Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case-control study with a mean 7-year follow-up.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412.
PubMed Abstract available

SHAHZAD UB, Hanif U, Aiman U
From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies.
Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07457.
PubMed

YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies".
Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07466.
PubMed

PARK JH, Kwon O, Choi JH, Yeom JS, et al
Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449.
PubMed Abstract available

STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al
Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443.
PubMed Abstract available

GHASEMINEJAD-RAEINI A, Hoveidaei AH, Zarepour F, Taghavi SP, et al
Notable lacking of bone mineral density measurement in cushing syndrome: a nationwide study based on the US insurance claim database.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07418.
PubMed Abstract available

PARK JW, Kim HY, Kim KM, Kim J, et al
Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022).
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429.
PubMed Abstract available

BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440.
PubMed Abstract available

ZHANG Q, Gao W, Xu X, Cui R, et al
Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis patients.
Osteoporos Int. 2025 Mar 4. doi: 10.1007/s00198-025-07448.
PubMed Abstract available

ENRIQUE LR, Francisco TN, Inigo EF, Cristina OT, et al
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM.
Osteoporos Int. 2025;36:375-389.
PubMed Abstract available

ZHOU K, Zhu Y, Luo X, Yang S, et al
A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification.
Osteoporos Int. 2025;36:521-530.
PubMed Abstract available

LAURSEN N, Solling AS, Harslof T, Langdahl B, et al
Clinical experience with denosumab discontinuation.
Osteoporos Int. 2025;36:435-446.
PubMed Abstract available

February 2025

PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al
Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436.
PubMed Abstract available

LIU J, Zhang Y, Yu W, Sun L, et al
TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423.
PubMed Abstract available

KANIS JA, Johansson H, McCloskey EV, Liu E, et al
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397.
PubMed Abstract available

ONTAN MS, Isik AT
Author response to: OSIN-D-24-01894 comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
Osteoporos Int. 2025 Feb 12. doi: 10.1007/s00198-025-07387.
PubMed

MO S, Gu Y
Comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
Osteoporos Int. 2025 Feb 11. doi: 10.1007/s00198-025-07416.
PubMed

CHEN R, Gong K, Chen W, Chen Z, et al
Author response to: OSIN-D-24-01898: Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07388.
PubMed

SHAO J, Zhang H, Fei Q
Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07417.
PubMed

LO JC, Chandra M, Khan MM, Barzilay J, et al
Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372.
PubMed Abstract available

MAKKAR B, Obremskey W, Avidano R, Ott S, et al
The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
PubMed Abstract available

NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
Association between vertebral fractures and brain volume: insights from a community cohort study.
Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
PubMed Abstract available

TICINESI A, Siniscalchi C, Meschi T, Nouvenne A, et al
Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.
Osteoporos Int. 2025;36:167-191.
PubMed Abstract available

BINKLEY N, Sempos CT, Borchardt G, Larsen J, et al
Association of standardized serum 25-hydroxyvitamin D with falls in post-menopausal women.
Osteoporos Int. 2025;36:255-264.
PubMed Abstract available

January 2025

NOOR A, Nabi R, Khan HT, Noor A, et al
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models.
Osteoporos Int. 2025 Jan 29. doi: 10.1007/s00198-025-07396.
PubMed

KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
PubMed Abstract available

NASO CM, Lin SY, Song G, Xue H, et al
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005-2018.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07395.
PubMed Abstract available

BROOKS ELG, Tangney CC, Ritz EM
Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07394.
PubMed Abstract available

PATRA S
Response to the letter "OSIN-24-D-01312, letter to the editor commenting on 'evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India'".
Osteoporos Int. 2025 Jan 23. doi: 10.1007/s00198-024-07354.
PubMed

YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case-control study.
Osteoporos Int. 2025 Jan 16. doi: 10.1007/s00198-025-07386.
PubMed Abstract available

LI X, Cheng L
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07389.
PubMed

DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
PubMed Abstract available

LIU Z, Tian M, Duan L
Enhancing emergency management for osteoporotic patients: a commentary on physical activity and mortality insights.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07371.
PubMed

LEE S, Hong N, Cho SJ, Shin S, et al
Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07336.
PubMed Abstract available

ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
PubMed Abstract available

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
PubMed

HUANG Z, Liao TC, Chuang AT, Shao SC, et al
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381.
PubMed Abstract available

CAO D, Cao Z, Liu A
Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
PubMed

CHEN F, Luo J, Li L
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12-19 years.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07349.
PubMed Abstract available

BUGBIRD AR, Boisvert NMJ, Burt LA, Boyd SK, et al
Choose your mother wisely: the familial resemblance of bone adaptation.
Osteoporos Int. 2025;36:141-149.
PubMed Abstract available

December 2024

RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al
Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults.
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373.
PubMed Abstract available

ALHARTHY A
Assessment of trabecular bone Hounsfield units in the lumbar spine for osteoporosis evaluation in individuals aged 65 and above: a review.
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07340.
PubMed Abstract available

YUE X, Shi S
Error in Mendelian randomization analysis in "Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma".
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07344.
PubMed

LIN YC, Chiang PH, Huang JY, Wu WS, et al
Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
PubMed Abstract available

NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
PubMed Abstract available

BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
PubMed Abstract available

YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
PubMed Abstract available

CAO D, Chen J, Yu W
Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
PubMed

ERDEN Y, Temel MH, Bagcier F
Author response to: OSIN-D-24-00381, artificial intelligence insights into osteoporosis.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07323.
PubMed

PARK HJ, Kim MG, Yoo YS, Lee B, et al
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07335.
PubMed

SONI M, Shabil M, Sah S
Comment on "Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis".
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07350.
PubMed

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
PubMed

VAN OOSTWAARD M, van den Bergh JP, Wyers CE
Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
PubMed

RAZA MH, Bhutta ME, Siddique MH
Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
PubMed

NARLA RR, Adler RA
Rationale for osteoporosis screening in men.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
PubMed Abstract available

KIM CH, Kim K, Kim JW
The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
PubMed Abstract available

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
PubMed

GU C, Cui Y
Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
PubMed

SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
PubMed Abstract available

PASQUINUCCI E, Limardo M, Salerno FR, Luise CM, et al
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports.
Osteoporos Int. 2024;35:2231-2234.
PubMed Abstract available

MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
Osteoporos Int. 2024;35:2145-2151.
PubMed Abstract available

TSAI JN, Jordan M, Lee H, Leder BZ, et al
One versus 2 years of alendronate following denosumab: the CARD extension.
Osteoporos Int. 2024;35:2225-2230.
PubMed Abstract available

RATHMANN W, Kostev K
Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study.
Osteoporos Int. 2024;35:2099-2106.
PubMed Abstract available

November 2024

CHEN R, Gong K, Chen W, Chen Z, et al
Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018.
Osteoporos Int. 2024 Nov 29. doi: 10.1007/s00198-024-07324.
PubMed Abstract available

AZAD TD, Wu RJ, Anderson KE, Darden M, et al
Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
PubMed Abstract available

ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
PubMed Abstract available

DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
PubMed Abstract available

DAUNGSUPAWONG H, Wiwanitkit V
Artificial intelligence insights into osteoporosis: comment.
Osteoporos Int. 2024 Nov 7. doi: 10.1007/s00198-024-07102.
PubMed

October 2024

EVERTS-GRABER J, Reichenbach S, Lehmann T
Response to the Letter to the Editor regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland" by Yang and colleagues.
Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07282.
PubMed

YANG J, Cao D, Liu A
Letter to the Editor Regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland".
Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07281.
PubMed

CAO D, Gu N, Liu A
Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
PubMed

ADESINA OO, Jenkins IC, Galvao F, de Moura AC, et al
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.
Osteoporos Int. 2024 Oct 22. doi: 10.1007/s00198-024-07268.
PubMed Abstract available

ZHOU K, Li R, Wang J
Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
PubMed

HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
Letter to editor: rebuttal to OSIN-D-24-01254 "RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07257.
PubMed

DAUNGSUPAWONG H, Wiwanitkit V
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07256.
PubMed

SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
PubMed Abstract available

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
PubMed Abstract available

CARDINALI DP, Reiter RJ
Clinical use of melatonin in osteoporosis: Expectations still unmet.
Osteoporos Int. 2024 Oct 18. doi: 10.1007/s00198-024-07261.
PubMed

PERSSON R, Hagberg KW, Pranschke E, Vasilakis-Scaramozza C, et al
Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink.
Osteoporos Int. 2024 Oct 14. doi: 10.1007/s00198-024-07262.
PubMed Abstract available

DU J, Cui H, Zhao Y, Xue H, et al
Correction: Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: A mendelian randomization study.
Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07271.
PubMed

CHEN H, Lou Y, Fei S, Luo J, et al
Association between physical activity and mortality in patients with osteoporosis: a cohort study of NHANES.
Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07280.
PubMed Abstract available

BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
PubMed Abstract available

AWAN EF, Farooqi HA, Nabi R
Advancing bone health strategies in Duchenne muscular dystrophy: the role of BMD monitoring in transforming prognosis.
Osteoporos Int. 2024;35:1865-1866.
PubMed

DENG X, Wu X, Sun Z, Liu Q, et al
Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients.
Osteoporos Int. 2024;35:1807-1815.
PubMed Abstract available

September 2024

TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
PubMed Abstract available

GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
PubMed Abstract available

MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
PubMed Abstract available

DU J, Cui H, Zhao Y, Xue H, et al
Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: a Mendelian randomization study.
Osteoporos Int. 2024 Sep 23. doi: 10.1007/s00198-024-07249.
PubMed Abstract available

CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07245.
PubMed

ZHAO AS, Liu Y, Mulvey JJ, Tchang BG, et al
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
Osteoporos Int. 2024 Sep 17. doi: 10.1007/s00198-024-07243.
PubMed Abstract available

GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
PubMed Abstract available

ARMUTCU F, McCloskey E
Insulin resistance, bone health, and fracture risk.
Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
PubMed Abstract available

JAIN RK
Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
PubMed

MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
Osteoporos Int. 2024;35:1573-1584.
PubMed Abstract available

August 2024

LIN CJ, Liu SJ, Lin KY
Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
PubMed

LI J, Zheng J
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
PubMed

HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07233.
PubMed Abstract available

FAN Z, Zhao J, Chen J, Hu W, et al
Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
PubMed Abstract available

KHADIVI G, Akhtari A, Sharifi F, Zargarian N, et al
Diagnostic accuracy of artificial intelligence models in detecting osteoporosis using dental images: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 23. doi: 10.1007/s00198-024-07229.
PubMed Abstract available

CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
Author Response to Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07192.
PubMed

TRAN TS, Bliuc D, Blank RD, Center JR, et al
Fracture risk assessment in the presence of competing risk of death.
Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
PubMed Abstract available

TAO J, Li H, Wang H, Tan J, et al
Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity.
Osteoporos Int. 2024 Aug 13. doi: 10.1007/s00198-024-07217.
PubMed Abstract available

YUAN K, Liu Q, Luo P, Wang C, et al
Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 12. doi: 10.1007/s00198-024-07220.
PubMed Abstract available

MCCARROLL K, Fitzpatrick D, Lannon R
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
PubMed

KUMAR S, Gild ML, McDonald MM, Kim AS, et al
Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
PubMed

WANG L, Guo X, Qin J, Jin Z, et al
Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07225.
PubMed Abstract available

ZENG Y, Yang Y, Wang J, Meng G, et al
The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
PubMed Abstract available

HADJI P, Kamali L, Thomasius F, Horas K, et al
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
PubMed Abstract available

KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
PubMed Abstract available

HU F, Li X, Zhao D, Chen C, et al
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis.
Osteoporos Int. 2024 Aug 1. doi: 10.1007/s00198-024-07190.
PubMed Abstract available

KANIS JA, Dawson-Hughes B, Campusano C, Cooper C, et al
IOF position on scientists and societies operating in conflict zones.
Osteoporos Int. 2024;35:1323-1328.
PubMed Abstract available

July 2024

PADERNO A, Gomes EJA, Gilberg L, Maerkisch L, et al
Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07206.
PubMed

TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
PubMed Abstract available

REGINSTER JY, Czerwinski E, Wilk K, Borowy P, et al
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.
Osteoporos Int. 2024 Jul 23. doi: 10.1007/s00198-024-07161.
PubMed Abstract available

PATRA S, Boro H, Porchezhian P, Khan N, et al
Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India.
Osteoporos Int. 2024 Jul 22. doi: 10.1007/s00198-024-07198.
PubMed Abstract available

LE HV, Van BW, Shahzad H, Teng P, et al
Fracture liaison service-a multidisciplinary approach to osteoporosis management.
Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
PubMed Abstract available

SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
PubMed Abstract available

PADERNO A, Ataide Gomes EJ, Gilberg L, Maerkisch L, et al
Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
Osteoporos Int. 2024 Jul 10. doi: 10.1007/s00198-024-07179.
PubMed Abstract available

JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
PubMed Abstract available

MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
Birth weight and birth length affect future fracture risk differently in men and women.
Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
PubMed Abstract available

KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
PubMed Abstract available

BENSKY MJ, Adler L, Banon T, Gabay L, et al
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
PubMed

PARK SY, Ahn SH, Bae GH, Jang S, et al
Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
PubMed Abstract available

MCCARROLL K, Carroll T, Neville M, Fitzpatrick D, et al
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review.
Osteoporos Int. 2024;35:1299-1302.
PubMed Abstract available

June 2024

PU X, Liu B, Wang D, Xiao W, et al
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening.
Osteoporos Int. 2024 Jun 28. doi: 10.1007/s00198-024-07164.
PubMed Abstract available

CORDOVA LA, Gonzalez-Quintanilla D, Heymann D
Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?
Osteoporos Int. 2024 Jun 27. doi: 10.1007/s00198-024-07173.
PubMed

EVERTS-GRABER J, Wenger M, Oser S, Studer U, et al
The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland.
Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07155.
PubMed Abstract available

HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
PubMed Abstract available

BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
PubMed Abstract available

MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
PubMed Abstract available

SO E, Juels C, Scott RT, Sietsema DL, et al
A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
PubMed Abstract available

XU MZ, Lu K, Ye YW, Xu SM, et al
Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
PubMed Abstract available

KUMAR S, Gild ML, McDonald MM, Kim AS, et al
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
PubMed Abstract available

LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
PubMed Abstract available

TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
Developing fracture liaison service framework based on comparative analysis and scoping review.
Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
PubMed Abstract available

PLAIS N, Gallego-Bustos J, Mahillo-Fernandez I, Tome-Bermejo F, et al
Letter to the editor.
Osteoporos Int. 2024;35:1105-1106.
PubMed

GUO DM, Weng YZ, Yu ZH, Li SH, et al
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation.
Osteoporos Int. 2024;35:1049-1059.
PubMed Abstract available

ZHOU L, Zhou H, Xu H, Sun X, et al
Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
Osteoporos Int. 2024;35:997-1005.
PubMed Abstract available

May 2024

DENG L, Shuai P, Liu Y, Yong T, et al
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07136.
PubMed Abstract available

PARK YB, Kim M, Nam HC, Jeon JW, et al
Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
PubMed Abstract available

KNIGHT KJ, Fordham RJ, Crabtree NJ, Knapp KM, et al
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.
Osteoporos Int. 2024 May 25. doi: 10.1007/s00198-024-07120.
PubMed Abstract available

CHEN Y, Miao Y, Zhang Q
Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07126.
PubMed Abstract available

YUE YS, Liu Y, Lu K, Shi Q, et al
Outdoor walking, genetic predisposition, and the risk of incident osteoporosis among older adults: A prospective large population-based cohort study.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07122.
PubMed Abstract available

MORENO-RABIE C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, et al
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07108.
PubMed Abstract available

WANG X, Zhao X
Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
PubMed

HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
PubMed

ANSARI H, Jaglal S, Cheung AM, Jain R, et al
Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
PubMed Abstract available

LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
PubMed Abstract available

ALI A, Huszti E, Noordin S, Ali U, et al
Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
PubMed Abstract available

KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
PubMed Abstract available

KUSAKABE T, Ishihara Y, Kitamura T, Yasoda A, et al
Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta.
Osteoporos Int. 2024 May 8. doi: 10.1007/s00198-024-07089.
PubMed

XIAO X, Wu Q
Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
PubMed Abstract available

LIU B, Ng CY, La PBD, Wong P, et al
Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
PubMed Abstract available

April 2024

PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
PubMed Abstract available

GOLD DT, Beckett T, Deal C, James AL, et al
Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
PubMed Abstract available

WANG M, Seibel MJ
Secondary fracture prevention in primary care: a narrative review.
Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
PubMed Abstract available

ZUBICK P, Dahlke S
Family/caregiver influence on osteoporosis management for older people: an integrative review.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
PubMed Abstract available

AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
PubMed Abstract available

WU J, Li J, Yan Z, Yu X, et al
Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
PubMed Abstract available

CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
PubMed Abstract available

LANE J, Langdahl B, Stone M, Kurth A, et al
Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
PubMed Abstract available

GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
PubMed Abstract available

ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
PubMed Abstract available

FUJITA N, Ono Y, Hashimoto K, Kawamura Y, et al
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.
Osteoporos Int. 2024;35:733-736.
PubMed Abstract available

WHITING PS, Hare K, Krueger D, Borchardt G, et al
Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
PubMed Abstract available

March 2024

KOBAYASHI T, Morimoto T, Mawatari M
Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
PubMed

CAI Y, Jun G, Zhuang X
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
PubMed Abstract available

DANAZUMI MS, Lightbody N, Dermody G
Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
PubMed Abstract available

LORENTZON M, Litsne H, Axelsson KF
The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
PubMed Abstract available

LI D, Mao SS, Budoff MJ
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
PubMed Abstract available

PARK HJ, Kim MG, Yoo YS, Lee B, et al
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-analysis.
Osteoporos Int. 2024 Mar 21. doi: 10.1007/s00198-024-07065.
PubMed

PLUSKIEWICZ W, Tabor E
The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
PubMed

DAS L, Laway BA, Sahoo J, Dhiman V, et al
Bone mineral density, turnover, and microarchitecture assessed by second-generation high-resolution peripheral quantitative computed tomography in patients with Sheehan's syndrome.
Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07062.
PubMed Abstract available

MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
The yield of routine laboratory examination in osteoporosis evaluation in primary care.
Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
PubMed Abstract available

TAGUCHI A
Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
PubMed

PARK HJ, Kim MG, Yoo YS, Lee BR, et al
Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis.
Osteoporos Int. 2024 Mar 13. doi: 10.1007/s00198-024-07061.
PubMed Abstract available

CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
PubMed Abstract available

HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
Associations between ultra-distal forearm bone mineral density and incident fracture in women.
Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
PubMed Abstract available

CHEN L, Li C, Chen H, Xie Y, et al
Cross-sectional studies of the causal link between asthma and osteoporosis: insights from Mendelian randomization and bioinformatics analysis.
Osteoporos Int. 2024 Mar 2. doi: 10.1007/s00198-024-07037.
PubMed Abstract available

February 2024

BLAY R, Flores LE, Kupzyk K, Waltman N, et al
Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.
Osteoporos Int. 2024 Feb 17. doi: 10.1007/s00198-023-07008.
PubMed Abstract available

PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
PubMed Abstract available

ZHANG H, Yang F, Cao Z, Xu Y, et al
The influence of iron on bone metabolism disorders.
Osteoporos Int. 2024;35:243-253.
PubMed Abstract available

YANG Q, He J, Yuan F
Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period.
Osteoporos Int. 2024;35:309-316.
PubMed Abstract available

RAMCHAND SK, Tsai JN, Lee H, Sassana-Khadka G, et al
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Osteoporos Int. 2024;35:255-263.
PubMed Abstract available

January 2024

EBINA K, Nagayama Y, Kashii M, Tsuboi H, et al
An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.
Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07019.
PubMed Abstract available

YU W, Guan WM, Hayashi D, Lin Q, et al
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
PubMed Abstract available

CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
PubMed

BENNETT MJ, Center JR, Perry L
Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
PubMed Abstract available

SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
PubMed Abstract available

IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
PubMed Abstract available

JEON S, Yu D, Kim S, Kim SW, et al
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
PubMed Abstract available

CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
PubMed Abstract available

BYUN SE, Kim H, Lee SY, Kim SM, et al
Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
PubMed Abstract available

SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
PubMed Abstract available

VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
PubMed Abstract available

ZENG L, Li Y, Hong C, Wang J, et al
Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-06996.
PubMed Abstract available

LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
PubMed Abstract available

CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
PubMed Abstract available

MULKERRIN P, O'Shea F, Fitzgerald G
Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
PubMed

December 2023

MCCARROLL K, Fitzpatrick D, McCormack M, Abdelfadil S, et al
Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.
Osteoporos Int. 2023 Dec 28. doi: 10.1007/s00198-023-07006.
PubMed Abstract available

CHEN H, Zhu X, Zhou Q, Pu X, et al
Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis.
Osteoporos Int. 2023 Dec 27. doi: 10.1007/s00198-023-06999.
PubMed Abstract available

MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.
Osteoporos Int. 2023 Dec 26. doi: 10.1007/s00198-023-07000.
PubMed

DING W, Huang Y, Li G, Dong Y, et al
Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence.
Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-07004.
PubMed Abstract available

MAGNO LAV, Tameirao DR, Alves LF, Guimaraes NS, et al
Effect of recreational cannabis use on bone mineral density: a systematic review.
Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-06992.
PubMed Abstract available

CHAVASSIEUX P, Roux JP, Chapurlat R
Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level.
Osteoporos Int. 2023 Dec 22. doi: 10.1007/s00198-023-06972.
PubMed Abstract available

YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
PubMed Abstract available

YOO JE, Huh Y, Kim E, Park SH, et al
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
PubMed Abstract available

GUIMARAES GC, Coelho JBC, Silva JGO, de Sant'Ana ACC, et al
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health.
Osteoporos Int. 2023 Dec 6. doi: 10.1007/s00198-023-06991.
PubMed Abstract available

HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
PubMed Abstract available

November 2023

NIZNIK JD, Kelley CJ, Fasth L, Colon-Emeric C, et al
Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
Osteoporos Int. 2023 Nov 18. doi: 10.1007/s00198-023-06967.
PubMed Abstract available

BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
PubMed Abstract available

CHEN KH, Su CM, Liu WJ, Tzeng HE, et al
The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study.
Osteoporos Int. 2023 Nov 10. doi: 10.1007/s00198-023-06947.
PubMed Abstract available

KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
PubMed Abstract available

NAJAFI S, Mohammadkhah F, Ebrahimi MM, Harsini PA, et al
Effect of educational intervention on preventing osteoporosis in postmenopausal women.
Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06962.
PubMed Abstract available

AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
The incremental risk of fragility fractures in aging men.
Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
PubMed Abstract available

CHEN Q, Tu Z, Ai Y, Li W, et al
Forearm bone mineral density predicts screw loosening after lumbar fusion similar to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis.
Osteoporos Int. 2023 Nov 3. doi: 10.1007/s00198-023-06957.
PubMed Abstract available

October 2023

HAN S, Kim S, Yeh EJ, Suh HS, et al
Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
PubMed Abstract available

INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
PubMed Abstract available

HEUCHERT J, Koziel S, Spinek AE
Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis - meta-analysis and systematic review.
Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06949.
PubMed Abstract available

LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
PubMed Abstract available

KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
PubMed

KOVACS CS
Fraudulent, duplicate publication of pregnancy/lactation data in Osteoporosis International.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06939.
PubMed

ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
PubMed Abstract available

PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
PubMed Abstract available

GROVLE L, Haugen AJ, Johansen M, Hasvik E, et al
The terminologies of transient, migratory, or localized osteoporosis, and bone marrow edema syndrome: a scoping review.
Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06929.
PubMed Abstract available

YAN F, Wu L, Lang J, Huang Z, et al
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
PubMed Abstract available

LI N, van den Bergh JP, Boonen A, Wyers CE, et al
Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
PubMed Abstract available

MAKRAS P, Yavropoulou MP, Polyzos SA, Papapoulos SE, et al
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
Osteoporos Int. 2023 Oct 2. doi: 10.1007/s00198-023-06931.
PubMed Abstract available

OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
Osteoporos Int. 2023;34:1799-1804.
PubMed Abstract available

BAGHERIFARD A, Hosseinzadeh A, Koosha F, Sheibani M, et al
Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
Osteoporos Int. 2023;34:1677-1701.
PubMed Abstract available

September 2023

MAAS L, Raskin N, van Onna M, Cornelissen D, et al
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
PubMed Abstract available

SOLOMON DH, Ruppert K, Cauley JA, Lian Y, et al
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women's Health Across the Nation (SWAN).
Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06915.
PubMed Abstract available

HUNG WC, Lin YL, Cheng TT, Chin WL, et al
Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
PubMed Abstract available

FUJISHIMA R, Ushimaru S, Sumi H, Aso M, et al
Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.
Osteoporos Int. 2023 Sep 19. doi: 10.1007/s00198-023-06898.
PubMed

LIU X, Makaroff KE, Almario CV, Khalil C, et al
Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
PubMed Abstract available

ELWAKIL W, El Gaafary M, El Miedany Y
Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
PubMed Abstract available

CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
PubMed Abstract available

LEE RH, Curtis J, Drake MT, Bobo Tanner S 4th, et al
Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients.
Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06912.
PubMed Abstract available

LU K, Wu YM, Shi Q, Gong YQ, et al
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
PubMed Abstract available

NICOLAES J, Liu Y, Zhao Y, Huang P, et al
External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
PubMed Abstract available

PENG T, Zeng X, Li Y, Li M, et al
A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screening.
Osteoporos Int. 2023 Sep 5. doi: 10.1007/s00198-023-06900.
PubMed Abstract available

LIU J, Tang Y, Peng B, Tian C, et al
Bone mineral density is associated with composite dietary antioxidant index among US adults: results from NHANES.
Osteoporos Int. 2023 Sep 4. doi: 10.1007/s00198-023-06901.
PubMed Abstract available

KARPUZ S
Zoledronic acid-induced severe lymphopenia.
Osteoporos Int. 2023;34:1653-1655.
PubMed Abstract available

August 2023

MOAYYERI A, Warden J, Han S, Suh HS, et al
Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
PubMed Abstract available

WANG J, Xing F, Sheng N, Xiang Z, et al
Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey.
Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06896.
PubMed Abstract available

SHAHROUR E
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy).
Osteoporos Int. 2023 Aug 30. doi: 10.1007/s00198-023-06876.
PubMed

BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
PubMed Abstract available

BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
PubMed Abstract available

HONG N, Shin S, Lee S, Rhee Y, et al
Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
PubMed Abstract available

ABDALBARY M, El-Husseini A
Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06874.
PubMed

TURABI RY, Sheehan KJ
Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
PubMed

MARTINS MJ
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763-774.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06873.
PubMed

MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
The importance of structural barriers of osteoporotic hip fracture in the elderly.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
PubMed

LI W, Zhao H, Zhou S, Xiong Z, et al
Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06880.
PubMed Abstract available

KANIS JA, Johansson H, McCloskey EV, Liu E, et al
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
PubMed Abstract available

SEO DH, Jeong Y, Cho Y, Kim SH, et al
Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
PubMed Abstract available

FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
PubMed

July 2023

HE D, Liu H, Wei W, Zhao Y, et al
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank.
Osteoporos Int. 2023 Jul 27. doi: 10.1007/s00198-023-06852.
PubMed Abstract available

THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
PubMed Abstract available

EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
PubMed Abstract available

MAZEDA C, Barcelos A
Gender differences in osteoporosis.
Osteoporos Int. 2023 Jul 20. doi: 10.1007/s00198-023-06858.
PubMed

TAN EH, Robinson DE, Jodicke AM, Mosseveld M, et al
Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837.
PubMed Abstract available

SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
PubMed Abstract available

HASEGAWA T
Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wo
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06835.
PubMed

SOMAY E
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06821.
PubMed

JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
PubMed Abstract available

SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
PubMed Abstract available

June 2023

SCHOUSBOE JT, Binkley N, Leslie WD
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
PubMed Abstract available

MOON RJ, Reginster JY, Al-Daghri NM, Thiyagarajan JA, et al
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Osteoporos Int. 2023 Jun 23. doi: 10.1007/s00198-023-06827.
PubMed Abstract available

KADRI A, Binkley N, Hernando D, Anderson PA, et al
Author response to letter to editor: OSIN-D-23-00474, "letter to the editor regarding 'Opportunistic use of lumbar magnetic resonance imaging for osteoporosis screening'".
Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06808.
PubMed

PU X, Li H
Letter to the editor regarding "Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening".
Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06801.
PubMed

LIU FC, Luk KC, Chen YC
Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
Osteoporos Int. 2023 Jun 16. doi: 10.1007/s00198-023-06818.
PubMed Abstract available

HUANG G, Chen X, Chen Y, Liu W, et al
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population.
Osteoporos Int. 2023 Jun 12. doi: 10.1007/s00198-023-06807.
PubMed Abstract available

PASKINS Z, Moult A, Corp N, Bastounis A, et al
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
Osteoporos Int. 2023 Jun 9. doi: 10.1007/s00198-023-06806.
PubMed Abstract available

HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
Osteoporosis medication adherence tools: a systematic review.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
PubMed Abstract available

HAGINO H, Moriwaki K, Wada T, Osaki M, et al
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
PubMed Abstract available

KUNIHARA T, Tohmori H, Tsukamoto M, Kobayashi M, et al
Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
Osteoporos Int. 2023;34:1101-1109.
PubMed Abstract available

May 2023

LIN SM, Lin JY, Tu YK, Wu CH, et al
Association between bisphosphonate use and stroke risk: a meta-analysis.
Osteoporos Int. 2023 May 30. doi: 10.1007/s00198-023-06781.
PubMed Abstract available

LU K, Wu YM, Shi Q, Gong YQ, et al
The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
PubMed Abstract available

GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
Mortality among older adults with osteoporotic vertebral fracture.
Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
PubMed Abstract available

ZHU K, Hunter M, James A, Lim EM, et al
Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians.
Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06773.
PubMed Abstract available

LAI SW
Adipopenia associated with osteoporosis.
Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06797.
PubMed

KWON H, Han KD, Kim BS, Moon SJ, et al
Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
PubMed Abstract available

RASHIDI MM, Saeedi Moghaddam S, Azadnajafabad S, Heidari-Foroozan M, et al
Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990-2019.
Osteoporos Int. 2023 May 23. doi: 10.1007/s00198-023-06778.
PubMed Abstract available

KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
PubMed Abstract available

YANG H, Bai J, Li L, Yang Y, et al
Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
PubMed Abstract available

AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
PubMed Abstract available

AVGERINOU C, Petersen I, Clegg A, West RM, et al
Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
PubMed Abstract available

METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
PubMed Abstract available

April 2023

HO-PHAM LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, et al
Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study.
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06757.
PubMed Abstract available

RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
PubMed Abstract available

MOON RJ, Green HD, D'Angelo S, Godfrey KM, et al
The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis.
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06751.
PubMed Abstract available

BENNETT MJ, Center JR, Perry L
Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
PubMed Abstract available

HILL EC, O'Donnell L
Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample.
Osteoporos Int. 2023 Apr 21. doi: 10.1007/s00198-023-06760.
PubMed Abstract available

CHANG CM, Chen YC, Wu WT, Lin TK, et al
Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study.
Osteoporos Int. 2023 Apr 20. doi: 10.1007/s00198-023-06756.
PubMed Abstract available

HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday rea
Osteoporos Int. 2023 Apr 13. doi: 10.1007/s00198-023-06745.
PubMed

PONZANO M, Tibert N, Brien S, Funnell L, et al
Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
PubMed

ICONARU L, Charles A, Baleanu F, Moreau M, et al
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
PubMed Abstract available

KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
PubMed Abstract available

TANG Y, Zhang L, Ye D, Zhao A, et al
Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
PubMed Abstract available

MATTICK LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
Osteoporos Int. 2023;34:693-701.
PubMed Abstract available

March 2023

LEGRAND A, Autrusseau F, Bandiaky ON, Idiri K, et al
Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06724.
PubMed

NICKEL B, Krueger D, Borchardt G, Andersen L, et al
Intraoperative physician assessment of bone: correlation to bone mineral density.
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06729.
PubMed Abstract available

GOEL H, Binkley N, Hans D, Leslie WD, et al
Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
PubMed Abstract available

LIN Z, Shi G, Liao X, Liu W, et al
Effect of pulmonary function on bone mineral density in the United States: results from the NHANES 2007-2010 study.
Osteoporos Int. 2023 Mar 23. doi: 10.1007/s00198-023-06727.
PubMed Abstract available

BINKLEY N, Nickel B, Anderson PA
Periprosthetic fractures: an unrecognized osteoporosis crisis.
Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
PubMed Abstract available

BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
Epidemiology of male osteoporosis in Denmark (1996-2018).
Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
PubMed Abstract available

EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
PubMed Abstract available

HANS D, McDermott M, Huang S, Kim M, et al
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
PubMed Abstract available

TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
PubMed Abstract available

HU J, Li Y, Wang Z, Li X, et al
Association of plant-based dietary patterns with the risk of osteoporosis in community-dwelling adults over 60 years: a cross-sectional study.
Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06700.
PubMed Abstract available

February 2023

JUNG SY, Cho EB, Han KD, Jung JH, et al
Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
PubMed Abstract available

HE D, Pan C, Zhao Y, Wei W, et al
Exome-wide screening identifies novel rare risk variants for bone mineral density.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
PubMed Abstract available

XIAO X, Wu Q
Ethnic disparities in fracture risk assessment using polygenic scores.
Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
PubMed Abstract available

YE C, Lee K, Leslie WD, Lin M, et al
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.
Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum